Treatment of human bone marrow with recombinant placenta immunoregulator ferritin results in myelopoiesis and T-cell suppression through modulation of the cytokine-chemokine networks.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples